Targacept to Report Second Quarter 2012 Financial Results on August 7, 2012
08:55 EDT 31 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical
company developing novel NNR Therapeutics (TM), today announced that it
will report financial results for the second quarter of 2012 on Tuesday,
August 7, 2012, a...
Other Sources for this Article
Targacept, Inc.
Alan Musso, 336-480-2186
SVP, Finance and
Administration and CFO
alan.musso@targacept.com
or
Linnden
Communications
Michelle Linn, 508-362-3087
linnmich@comcast.net
More From BioPortfolio on "Targacept to Report Second Quarter 2012 Financial Results on August 7, 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
